What is the official ID of this bill?
The official print number for this legislation is S 3509.
Strengthening Foreign Drug Facility Inspections for Citizen Safety.
New rules aim to enhance the safety of drugs available in the U.S. by allowing unannounced inspections of foreign manufacturing facilities. This means citizens can be more confident about the quality and safety of imported medications, as inspections will be more effective. Companies that do not agree to such inspections may face difficulties in bringing their products to the U.S. market.
Key points
Unannounced Inspections: U.S. authorities can conduct unannounced inspections of foreign drug manufacturing facilities supplying the U.S., enhancing product safety.
Exceptions to Notice: Advance notice for inspections will only be given if required by local law or to protect public health, always with minimal lead time.
Consequences of Refusal: Foreign companies refusing unannounced inspections may be deemed non-compliant, potentially blocking their drugs from the U.S. market.
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens
(explained here).
Start recording it now.